Yin Jiao, Wang Yan, Wang Sihong, Li Gang, Gu Hui, Chen Lizhu
Department of Ultrasound, Shengjing Hospital of China Medical University, Shenyang, China.
Key Laboratory of Health Ministry for Congenital Malformation, Shengjing Hospital of China Medical University, Shenyang, China.
Heliyon. 2024 Aug 13;10(16):e36060. doi: 10.1016/j.heliyon.2024.e36060. eCollection 2024 Aug 30.
Neural tube defects (NTDs) are severe congenital anomalies that result from the failure of early neural tube closure during fetal neurogenesis. They are the most common and severe congenital malformations of the central nervous system. Identifying reliable prenatal diagnostic ultrasound and molecular markers that can predict NTDs is of paramount importance. Early diagnosis of NTDs allows embryonic treatment and prevention strategies, which are crucial for reducing the disability rate associated with these malformations, reducing the burden on individuals and on society. The purpose of this comprehensive review was to summarize the ultrasound biomarkers between 11 and 13 weeks of gestation and the molecular biomarkers used in the diagnosis of NTDs, providing additional insights into early screening for NTDs.
神经管缺陷(NTDs)是严重的先天性异常,由胎儿神经发生过程中早期神经管闭合失败所致。它们是中枢神经系统最常见且最严重的先天性畸形。识别能够预测神经管缺陷的可靠产前诊断超声和分子标志物至关重要。神经管缺陷的早期诊断可实现胚胎治疗和预防策略,这对于降低与这些畸形相关的残疾率、减轻个人和社会负担至关重要。本综述的目的是总结妊娠11至13周期间的超声生物标志物以及用于诊断神经管缺陷的分子生物标志物,为神经管缺陷的早期筛查提供更多见解。